As many as one third of lactating women experience significant discomfort resulting in premature cessation of breastfeeding. Conventional approaches are frequently ineffective and commonly associated with adverse effects.[1]
Identification of a robust, colonizing probiotic strain serves as the basis for a safe, effective solution to this common, painful, and difficult-to-resolve problem.*
References:
1. Jiménez E, et al. Oral administration of Lactobacillus strains isolated from breast milk as an alternative. Appl Environ Microbiol. 2008,74(15):4650-4655.
2. Martín R, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003;143(6):754-758.
3. Olivares M, et al. (2016). Lactobacillus fermentum CECT5716, a human milk probiotic strain. Conference Proceedings of IPC2016. Paper presented at the International Scientific Conference on Probiotics and Prebiotics, Budapest (p. 109). IPC2016.
4. Maldonado-Lobón JA, et al. Lactobacillus fermentum CECT5716 reduces Staphylococcus load in the breastmilk of lactating mothers suffering breast pain: a randomized controlled trial. Breastfeed Med. 2015;10(9):425-432.